BioMarin Pharmaceutical Inc. (BMRN) Balance Sheet
As of 2026-06-30 (10-Q), BioMarin Pharmaceutical Inc. (BMRN) reported total assets of $11.7B, total liabilities of $5.4B and shareholders' equity of $6.3B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $874.0M. Long-term debt: $4.2B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BMRNBioMarin Pharmaceutical Inc.Follow BMRN — free
—
Price chart with a free account
- Market cap
- 10.8B
- P/E TTM
- 151.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.09 | 0.05 | 0.18 | 0.57 | 0.88 | 0.40 | 0.41 | 0.60 | 0.49 | 0.44 | 0.65 | 0.59 | 0.72 | 0.76 | 0.94 | 1.31 | 0.87 | |
| Short-term investments | 0.19 | 0.15 | 0.27 | 0.22 | 0.07 | 0.20 | 0.38 | 0.80 | 0.59 | 0.32 | 0.42 | 0.43 | 0.57 | 0.32 | 0.19 | 0.25 | 0.00 | |
| Receivables | 0.09 | 0.10 | 0.11 | 0.12 | 0.14 | 0.16 | 0.22 | 0.26 | 0.34 | 0.38 | 0.45 | 0.37 | 0.46 | 0.63 | 0.66 | 0.91 | 1.06 | |
| Inventory | 0.11 | 0.13 | 0.13 | 0.16 | 0.20 | 0.27 | 0.36 | 0.48 | 0.53 | 0.68 | 0.70 | 0.78 | 0.89 | 1.11 | 1.23 | 1.30 | 1.78 | |
| Current assets | 0.50 | 0.47 | 0.74 | 1.14 | 1.40 | 1.09 | 1.42 | 2.21 | 2.06 | 1.94 | 2.34 | 2.27 | 2.75 | 2.96 | 3.23 | 3.95 | 3.97 | |
| Total assets | 1.26 | 1.31 | 1.57 | 2.24 | 2.48 | 3.73 | 4.02 | 4.63 | 4.43 | 4.69 | 5.85 | 6.00 | 6.38 | 6.84 | 6.99 | 7.59 | 11.72 | |
| Current liabilities | 0.08 | 0.09 | 0.17 | 0.18 | 0.24 | 0.45 | 0.44 | 0.82 | 0.52 | 0.93 | 0.49 | 0.55 | 0.59 | 1.18 | 0.61 | 0.76 | 1.66 | |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.60 | 4.19 | |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.66 | |
| Total liabilities | 0.55 | 0.53 | 0.55 | 0.90 | 0.95 | 1.33 | 1.26 | 1.82 | 1.46 | 1.57 | 1.74 | 1.74 | 1.77 | 1.89 | 1.33 | 1.51 | 5.40 | |
| Shareholders' equity | 0.72 | 0.77 | 1.02 | 1.34 | 1.53 | 2.40 | 2.77 | 2.81 | 2.97 | 3.12 | 4.10 | 4.27 | 4.60 | 4.95 | 5.66 | 6.09 | 6.32 |
USD billions · SEC XBRL
BioMarin Pharmaceutical Inc. — questions
- How much cash does BioMarin Pharmaceutical Inc. have?
- $874.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does BioMarin Pharmaceutical Inc. have?
- $4.2B of long-term debt and $658.2M due within a year as of 2026-06-30.
- What are BioMarin Pharmaceutical Inc.'s total assets?
- $11.7B as of 2026-06-30.
- What is BioMarin Pharmaceutical Inc.'s shareholders' equity?
- $6.3B as of 2026-06-30.
Every figure on this page comes from BioMarin Pharmaceutical Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.